Siirry päänavigointiin
Siirry hakuun
Siirry pääsisältöön
Järjestys:
Keyphrases
Screening Approach
100%
CCR5 Receptor
95%
HIV-1 Inhibition
95%
Pharmacogenetic Testing
95%
CXCR4 Receptor
95%
FDA-approved Drugs
47%
Zika Virus
47%
NS2B-NS3
47%
Pharmacoinformatics
47%
3C-like Protease (3CLpro)
47%
Chymotrypsin
47%
Block Copolymer Micelles
47%
Molecular Dynamics Simulation Study
47%
Regret
47%
Goniometry
47%
NS3 Inhibitors
47%
Functional Block Copolymers
47%
SARS-CoV-2 Main Protease
47%
Weakly Basic Drug
47%
C-C Chemokine Receptor Type 5 (CCR5)
47%
Phosphorylase
47%
Enterococcus Faecalis
47%
Hop Compounds
47%
Omicron mutant
47%
Alchemical Free Energy Methods
47%
Dual Mode of Action
47%
6-prenylnaringenin
47%
Modulatory Effects
47%
Polymeric Nanoemulsions
47%
Quinoline
47%
GABAA Receptor (GABAAR)
47%
Amino Acid Derivatives
47%
Dynamic Prediction
47%
Binding Free Energy Change
47%
Protease
47%
Nucleophile
47%
Trypsin-like
47%
Market Violence
47%
Three-dimensional Construction
47%
Alternative Medicine
47%
Virus-mimetic
47%
Institutional Responses
47%
Amino Acids
47%
Nanovectors
47%
Destructive Entrepreneurship
47%
Novel Antimicrobials
47%
In Silico Characterization
47%
1,2,3-triazole
47%
Measurement Dynamics
47%
2-quinolone
47%
Pharmacology, Toxicology and Pharmaceutical Science
Chemokine Receptor CXCR4
95%
Chemokine Receptor CCR5
95%
Human Immunodeficiency Virus Fusion Inhibitor
95%
Zika Virus
47%
Enterococcus faecalis
47%
Phosphorylase
47%
Histidine
47%
Proteinase
47%
Chymotrypsin
47%
4 Aminobutyric Acid
47%
Quinoline Derivative
47%
Amino Acid Derivative
47%
Virtual Screening
47%
Pharmaceutics
47%
Nanoparticle
47%
Triazole Derivative
47%
Quinolone
47%
Drug Carrier
47%
Pinosylvin
47%
Receptor
47%
Transient Receptor Potential Channel A1
47%
Antimicrobial Resistance
47%
Antibiotics
47%
Phosphorylase Kinase
35%
Sunitinib
23%
Ankyrin
23%
Coronavirinae
23%
Humulon
23%
Viral Vector
23%
Dynamin
23%
Infectious Agent
23%
Antibacterial Activity
23%
Microbiome
23%
Molecular Mechanic
19%
Proteinase Inhibitor
15%
Paritaprevir
15%
Enteritis
15%
DNA Topoisomerase (ATP Hydrolysing)
15%
DNA Topoisomerase IV
15%
Quinolone Derivative
15%
Silica Gel
15%
Vanilloid Receptor 4
15%
Nanocarrier
13%
Allyl Compound
11%
Polyvinyl Derivative
11%
Amoxicillin
11%
Glycogen Phosphorylase
11%
Bacterial Enzyme
11%
Radioligand
11%
Glutamic Acid Derivative
11%
